Gong Zheng witnessed the signing, Chen Jining met with the CEO of the company, and this American pharmaceutical company signed a strategic cooperation agreement in Shanghai. China | Industry | Meeting
The Municipal Economic and Information Technology Commission, Minhang District Government, and Modena Corporation of the United States signed a strategic cooperation agreement in Shanghai on July 5th. Chen Jining, Secretary of the Municipal Party Committee, met with Stefan Bansell, CEO of Modena Company, and his delegation. Gong Zheng, Deputy Secretary of the Municipal Party Committee and Mayor, witnessed the signing of the contract.
Chen Jining introduced the latest developments in the biopharmaceutical industry in Shanghai. He said that the biopharmaceutical industry is one of the three leading industries that Shanghai is focusing on developing. After years of efforts, it has formed a relatively complete industrial chain and become an important gathering place for global pharmaceutical enterprises. We always benchmark against the highest international standards and the best level, comply with the transformation of research and development innovation models in the biopharmaceutical field, strengthen institutional supply, improve service systems, accelerate the construction of world-class biopharmaceutical industry clusters, and effectively enhance the core competitiveness of the industry. I hope that the signing of this strategic cooperation agreement will serve as an opportunity to accelerate the implementation of the Modena project, achieve physical operation as soon as possible, and promote the landing of more advanced technologies and innovative products in Shanghai. We will continue to create an international first-class business environment, provide efficient docking and convenient services for enterprises to invest in research and development, improve business layout in Shanghai, and help enterprises achieve better and faster development.
Ban Saier introduced the progress of related projects and the development and production business after his visit to Shanghai in April this year. He said that the signing of this important agreement has consolidated the efforts of all parties and will provide strong support for the company's core business layout in Shanghai, such as research and development and production. We fully feel the determination and action of China and Shanghai to promote the development of the biopharmaceutical industry, and are full of confidence in the future development of the industry. We will accelerate the landing of the Modena project in Shanghai, work together with Chinese partners to accelerate innovation and research and development, and better assist the development of the biopharmaceutical industry and benefit a large number of patients.
City leaders Li Zheng and Liu Duo participated in relevant activities.
Modena Corporation is a technologically leading innovative pharmaceutical enterprise, and its mRNA vaccines play an important role in combating infectious diseases. The strategic cooperation agreement signed by the three parties this time will focus on technological innovation and industrial development, accelerate the transformation of scientific and technological achievements, and help Shanghai build a world-class biopharmaceutical industry cluster.